SELECTA BIOSCIENCES INC

• WATERTOWN, MA How do I update this listing?

Create Email Alert

Selecta Biosciences is based out of Watertown. Selecta Biosciences, Inc. develops biopharmaceutical treatments. The Company produces nanoparticle immunomodulatory drugs and vaccines, which delivers bioactive molecules to specific immune cells in the body. Selecta Biosciences operates in the United States.Whalewisdom has at least 79 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2020-08-18. The notice included securities offered of Equity

Contact Info

selecta biosciences inc
65 GROVE STREET
WATERTOWN MA    02472
Business Phone: 617-923-1400
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-08-18 D BIOTECHNOLOGY Equity 25,000,000 25,000,000 0
2020-01-02 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 70,000,000 70,000,000 0
2019-09-04 D BIOTECHNOLOGY Equity 5,752,495 5,752,495 0
2017-07-11 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 50,000,000 50,000,000 0
2016-12-14 D BIOTECHNOLOGY Equity 4,999,984 4,999,984 0
2015-09-10 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 40,637,943 37,400,000 3,237,943
2015-04-23 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security 7,500,000 5,942,306 1,557,694
2014-08-28 D BIOTECHNOLOGY Equity 4,450,000 4,450,000 0
2014-07-15 D BIOTECHNOLOGY Equity 6,000,000 6,000,000 0
2014-04-09 D BIOTECHNOLOGY Equity 9,999,994 5,292,702 4,707,292
2011-11-17 D BIOTECHNOLOGY Equity 22,000,000 22,000,000 0
2011-11-17 D BIOTECHNOLOGY Equity 26,000,000 3,500,000 22,500,000
2010-04-06 D BIOTECHNOLOGY Equity 15,000,006 15,000,006 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ROBERT L. BRATZLER subscription required
    EXECUTIVE OFFICER DIRECTOR
AMIR NASHAT subscription required
    DIRECTOR
DOUGLAS COLE subscription required
    DIRECTOR
AYMERIC SALLIN subscription required
    DIRECTOR
CARL L. GORDON subscription required
    DIRECTOR
OMID FAROKHZAD subscription required
    DIRECTOR
ROBERT S. LANGER, JR. subscription required
    DIRECTOR
PETER BARTON HUTT subscription required
    DIRECTOR
GEORGE SIBER subscription required
    DIRECTOR
WERNER CAUTREELS subscription required
    EXECUTIVE OFFICER DIRECTOR
COLE DOUGLAS subscription required
    DIRECTOR
ROBERT LANGER subscription required
    DIRECTOR
YURIY UDALTSOV subscription required
    DIRECTOR
DAVID SIEWERS subscription required
    EXECUTIVE OFFICER
EDWIN M. KANIA, JR. subscription required
    DIRECTOR
DAVID ABRAHAM subscription required
    EXECUTIVE OFFICER
LLOYD JOHNSTON subscription required
    EXECUTIVE OFFICER
TAKASHI KEI KISHIMOTO subscription required
    EXECUTIVE OFFICER
PETER KELLER subscription required
    EXECUTIVE OFFICER
LEYSAN SHAYDULLINA subscription required
    DIRECTOR
EARL SANDS subscription required
    EXECUTIVE OFFICER
TIMOTHY C. BARABE subscription required
    DIRECTOR
TIMOTHY SPRINGER subscription required
    DIRECTOR
PATRICK ZENNER subscription required
    DIRECTOR
CARSTEN BRUNN subscription required
    EXECUTIVE OFFICER DIRECTOR
ELONA KOGAN subscription required
    EXECUTIVE OFFICER
STEPHEN SMOLINSKI subscription required
    EXECUTIVE OFFICER
ALISON SCHECTER subscription required
    EXECUTIVE OFFICER
SCOTT D. MYERS subscription required
    DIRECTOR
BRADFORD DAHMS subscription required
    EXECUTIVE OFFICER
CARRIE COX subscription required
    DIRECTOR
STEPHEN SMOLINKSI subscription required
    EXECUTIVE OFFICER
GORAN ANDO subscription required
    DIRECTOR

Elevate your investments